This is a Validated Antibody Database (VAD) review about dogs CD81, based on 35 published articles (read how Labome selects the articles), using CD81 antibody in all methods. It is aimed to help Labome visitors find the most suited CD81 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
BD Biosciences
mouse monoclonal (JS-81)
  • western blot knockout validation; human; loading ...; fig 1a, 1b
BD Biosciences CD81 antibody (BD Pharmingen, JS-81) was used in western blot knockout validation on human samples (fig 1a, 1b). PLoS Pathog (2017) ncbi
BD Biosciences
mouse monoclonal (JS-81)
  • flow cytometry; human; loading ...; fig 4g
BD Biosciences CD81 antibody (BD, 555676) was used in flow cytometry on human samples (fig 4g). elife (2022) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; 1:20; loading ...; fig s4a, s4b
BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in flow cytometry on human samples at 1:20 (fig s4a, s4b). J Extracell Vesicles (2020) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in flow cytometry on human samples (fig s3). J Clin Invest (2019) ncbi
mouse monoclonal (JS-81)
  • western blot; human; loading ...; fig 6f
BD Biosciences CD81 antibody (BD Bioscience, 551112) was used in western blot on human samples (fig 6f). J Cell Biol (2018) ncbi
mouse monoclonal (JS-81)
  • western blot knockout validation; human; loading ...; fig 1a, 1b
BD Biosciences CD81 antibody (BD Pharmingen, JS-81) was used in western blot knockout validation on human samples (fig 1a, 1b). PLoS Pathog (2017) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; loading ...; tbl 2
In order to investigate the role of cell surface 90 kDa heat shock protein in cytokine response, BD Biosciences CD81 antibody (BD Bioscience, JS-81) was used in flow cytometry on human samples (tbl 2). J Leukoc Biol (2017) ncbi
mouse monoclonal (JS-81)
  • blocking or activating experiments; human; loading ...; fig 3a
BD Biosciences CD81 antibody (BD Biosciences, 555675) was used in blocking or activating experiments on human samples (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig 1c
  • western blot; human; fig 1b
In order to report the differential effector function by exosomes in communicating the toll like receptor activation state of the original activated cell, BD Biosciences CD81 antibody (BD Biosciences, 555676) was used in flow cytometry on human samples (fig 1c) and in western blot on human samples (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; 1:100
In order to study hepatitis C virus infection in mice with humanized CD81 and occludin, BD Biosciences CD81 antibody (BD Pharmigen, 551112) was used in flow cytometry on human samples at 1:100. J Virol (2017) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig 1d
BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in flow cytometry on human samples (fig 1d). J Virol (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD81 antibody (BD Biosciences, 551108) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD81 antibody (BD, 561956) was used in flow cytometry on human samples (fig 1d). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (JS-81)
  • western blot; human; fig 2
BD Biosciences CD81 antibody (BD Bioscience, 555675) was used in western blot on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig 1
BD Biosciences CD81 antibody (BD Biosciences, 561956) was used in flow cytometry on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, BD Biosciences CD81 antibody (BD Biosciences, 555676) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD81 antibody (BD, 555676) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; 1 ug/ml; fig 1
  • western blot; human; fig 1
In order to determine the contribution of occludin to hepatitis C virus infection, BD Biosciences CD81 antibody (BD Bioscience Pharmingen, JS-81) was used in flow cytometry on human samples at 1 ug/ml (fig 1) and in western blot on human samples (fig 1). Biol Pharm Bull (2016) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig 3c
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, BD Biosciences CD81 antibody (BD, JS-81) was used in flow cytometry on human samples (fig 3c). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; 1:200; fig 1
In order to assess the capacity of primary synovial fibroblasts to support hepatitis C virus propagation, BD Biosciences CD81 antibody (Becton Dickinson, JS-81) was used in flow cytometry on human samples at 1:200 (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (JS-81)
  • blocking or activating experiments; human; fig 5
  • immunocytochemistry; human; fig 1
BD Biosciences CD81 antibody (BD Pharmingen, 555675) was used in blocking or activating experiments on human samples (fig 5) and in immunocytochemistry on human samples (fig 1). Nat Protoc (2015) ncbi
mouse monoclonal (JS-81)
  • western blot; human; fig 6c
In order to study ectosome-mediated trafficking in fibroblasts, BD Biosciences CD81 antibody (BD Biosciences., 555675) was used in western blot on human samples (fig 6c). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BD Biosciences CD81 antibody (BD Pharmingen, 551112) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (JS-81)
  • other; human; loading ...; fig e4c
BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in other on human samples (fig e4c). Nature (2015) ncbi
mouse monoclonal (JS-81)
  • proximity ligation assay; human; loading ...; fig 13
  • immunocytochemistry; human; 1:50; loading ...; fig 2a
BD Biosciences CD81 antibody (BD Pharmingen, JS-81) was used in proximity ligation assay on human samples (fig 13) and in immunocytochemistry on human samples at 1:50 (fig 2a). J Biol Chem (2015) ncbi
mouse monoclonal (JS-81)
  • immunocytochemistry; human; fig 10
BD Biosciences CD81 antibody (BD PharMingen, 555675) was used in immunocytochemistry on human samples (fig 10). PLoS ONE (2015) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig s3d
  • western blot; human; 1:200; fig s1b
  • western blot; African green monkey; fig s1b
  • flow cytometry; rhesus macaque; fig s3d
  • western blot; rhesus macaque; fig s1b
In order to identify cellular determinants of interspecies hepatitis C virus transmission and establish an immunocompetent model system, BD Biosciences CD81 antibody (BD Pharmingen, JS-81) was used in flow cytometry on human samples (fig s3d), in western blot on human samples at 1:200 (fig s1b), in western blot on African green monkey samples (fig s1b), in flow cytometry on rhesus macaque samples (fig s3d) and in western blot on rhesus macaque samples (fig s1b). Hepatology (2015) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig 2
BD Biosciences CD81 antibody (BD Pharmingen, JS-81) was used in flow cytometry on human samples (fig 2). Immunol Cell Biol (2015) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human
  • immunocytochemistry; human
  • western blot; human; fig 1
BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in flow cytometry on human samples , in immunocytochemistry on human samples and in western blot on human samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; 1:500; loading ...; fig 6c
In order to develop an efficient system to culture hepatitis C virus, BD Biosciences CD81 antibody (BD Bioscience Pharmingen, JS-81) was used in flow cytometry on human samples at 1:500 (fig 6c). Jpn J Infect Dis (2015) ncbi
mouse monoclonal (JS-81)
  • blocking or activating experiments; human
In order to examine the roles of scavenger receptor class B type I, CD81, claudin 1, and occludin in Hepatitis C virus infection, BD Biosciences CD81 antibody (BD Biosciences, JS81) was used in blocking or activating experiments on human samples . J Virol (2014) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human; fig 1
In order to investigate the mechanisms of hepatitis C virus entry into multiple permissive human hepatocyte-derived cells, BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in flow cytometry on human samples (fig 1). J Gen Virol (2014) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human
In order to characterize CD81(+) and CD63(+) subpopulations of exosomes released from B-cell lymphoma cell lines, BD Biosciences CD81 antibody (BD Biosciences, 555676) was used in flow cytometry on human samples . Clin Ther (2014) ncbi
mouse monoclonal (JS-81)
  • flow cytometry; human
In order to investigate the role of diacylglycerol acyltransferase-1 in hepatitis C virus entry, BD Biosciences CD81 antibody (BD Biosciences, JS-81) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (JS-81)
  • blocking or activating experiments; human
BD Biosciences CD81 antibody (BD Pharmingen, JS81) was used in blocking or activating experiments on human samples . J Virol (2014) ncbi
mouse monoclonal (JS-81)
  • In-Cell Western; human
BD Biosciences CD81 antibody (BD Biosciences, 551108) was used in In-Cell Western on human samples . Thyroid (2013) ncbi
Articles Reviewed
  1. Ramos E, Tsai C, Jia Y, Cao Y, Manu M, Taftaf R, et al. Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. elife. 2022;11: pubmed publisher
  2. Crescitelli R, Lässer C, Jang S, Cvjetkovic A, Malmhäll C, Karimi N, et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J Extracell Vesicles. 2020;9:1722433 pubmed publisher
  3. Kretschmann S, Herda S, Bruns H, Russ J, van der Meijden E, Schlötzer Schrehardt U, et al. Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY. J Clin Invest. 2019;129:2952-2963 pubmed publisher
  4. Verweij F, Bebelman M, Jimenez C, Garcia Vallejo J, Janssen H, Neefjes J, et al. Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling. J Cell Biol. 2018;217:1129-1142 pubmed publisher
  5. Earnest J, Hantak M, Li K, McCray P, Perlman S, Gallagher T. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases. PLoS Pathog. 2017;13:e1006546 pubmed publisher
  6. Bzowska M, Nogieć A, Bania K, Zygmunt M, Zarebski M, Dobrucki J, et al. Involvement of cell surface 90 kDa heat shock protein (HSP90) in pattern recognition by human monocyte-derived macrophages. J Leukoc Biol. 2017;102:763-774 pubmed publisher
  7. Lee M, Yang J, Jo E, Lee J, Kim H, Bartenschlager R, et al. A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner. Sci Rep. 2017;7:44676 pubmed publisher
  8. Srinivasan S, Su M, Ravishankar S, Moore J, Head P, Dixon J, et al. TLR-exosomes exhibit distinct kinetics and effector function. Sci Rep. 2017;7:41623 pubmed publisher
  9. Ding Q, von Schaewen M, Hrebikova G, Heller B, Sandmann L, Plaas M, et al. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo. J Virol. 2017;91: pubmed publisher
  10. Trautz B, Pierini V, Wombacher R, Stolp B, Chase A, Pizzato M, et al. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor. J Virol. 2016;90:10915-10927 pubmed publisher
  11. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  12. Knickelbein J, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, et al. Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium. Invest Ophthalmol Vis Sci. 2016;57:4101-7 pubmed publisher
  13. Wong M, Chen S. Human Choline Kinase-? Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation. J Virol. 2016;90:9075-95 pubmed publisher
  14. Ramanathan A, Gusarova V, Stahl N, Gurnett Bander A, Kyratsous C. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes. PLoS ONE. 2016;11:e0154498 pubmed publisher
  15. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  16. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  17. Shirasago Y, Shimizu Y, Tanida I, Suzuki T, Suzuki R, Sugiyama K, et al. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection. Biol Pharm Bull. 2016;39:839-48 pubmed publisher
  18. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  19. Nadeem A, Thomas P, Ulf M, Elena N, Anggakusuma A, Mohamed B, et al. Cell culture-derived HCV cannot infect synovial fibroblasts. Sci Rep. 2015;5:18043 pubmed publisher
  20. March S, Ramanan V, Trehan K, Ng S, Galstian A, Gural N, et al. Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens. Nat Protoc. 2015;10:2027-53 pubmed publisher
  21. Santi A, Caselli A, Ranaldi F, Paoli P, Mugnaioni C, Michelucci E, et al. Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth. Biochim Biophys Acta. 2015;1853:3211-23 pubmed publisher
  22. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  23. Saeed M, Andreo U, Chung H, Espiritu C, Branch A, Silva J, et al. SEC14L2 enables pan-genotype HCV replication in cell culture. Nature. 2015;524:471-5 pubmed publisher
  24. Le Q, Blanchet M, Seidah N, Labonté P. Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9. J Biol Chem. 2015;290:23385-400 pubmed publisher
  25. Luo X, Fan Y, Park I, He J. Exosomes are unlikely involved in intercellular Nef transfer. PLoS ONE. 2015;10:e0124436 pubmed publisher
  26. Scull M, Shi C, De Jong Y, Gerold G, Ries M, von Schaewen M, et al. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology. 2015;62:57-67 pubmed publisher
  27. Skogberg G, Lundberg V, Berglund M, Gudmundsdottir J, Telemo E, Lindgren S, et al. Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens. Immunol Cell Biol. 2015;93:727-34 pubmed publisher
  28. Lambelé M, Koppensteiner H, Symeonides M, Roy N, Chan J, Schindler M, et al. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells. J Virol. 2015;89:3247-55 pubmed publisher
  29. Shirasago Y, Sekizuka T, Saito K, Suzuki T, Wakita T, Hanada K, et al. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus. Jpn J Infect Dis. 2015;68:81-8 pubmed publisher
  30. Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. J Virol. 2014;88:12644-55 pubmed publisher
  31. Matsuda M, Suzuki R, Kataoka C, Watashi K, Aizaki H, Kato N, et al. Alternative endocytosis pathway for productive entry of hepatitis C virus. J Gen Virol. 2014;95:2658-67 pubmed publisher
  32. Oksvold M, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, et al. Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells. Clin Ther. 2014;36:847-862.e1 pubmed publisher
  33. Sung P, Murayama A, Kang W, Kim M, Yoon S, Fukasawa M, et al. Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells. J Virol. 2014;88:9233-44 pubmed publisher
  34. Prentoe J, Serre S, Ramírez S, Nicosia A, Gottwein J, Bukh J. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus. J Virol. 2014;88:1725-39 pubmed publisher
  35. Blackard J, Kong L, Huber A, Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid. 2013;23:863-70 pubmed publisher